Effects of Enteric Environmental Modification by Coffee Components on Neurodegeneration in Rotenone-Treated Mice
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Epidemiological studies have shown that coffee consumption decreases the risk of Parkinson’s disease (PD). Caffeic acid (CA) and chlorogenic acid (CGA) are coffee components that have antioxidative properties. Rotenone, a mitochondrial complex I inhibitor, has been used to develop parkinsonian models, because the toxin induces PD-like pathology. Here, we examined the neuroprotective effects of CA and CGA against the rotenone-induced degeneration of central dopaminergic and peripheral enteric neurons. Male C57BL/6J mice were chronically administered rotenone (2.5 mg/kg/day), subcutaneously for four weeks. The animals were orally administered CA or CGA daily for 1 week before rotenone exposure and during the four weeks of rotenone treatment. Administrations of CA or CGA prevented rotenone-induced neurodegeneration of both nigral dopaminergic and intestinal enteric neurons. CA and CGA upregulated the antioxidative molecules, metallothionein (MT)-1,2, in striatal astrocytes of rotenone-injected mice. Primary cultured mesencephalic or enteric cells were pretreated with CA or CGA for 24 h, and then further co-treated with a low dose of rotenone (1–5 nM) for 48 h. The neuroprotective effects and MT upregulation induced by CA and CGA in vivo were reproduced in cultured cells. Our data indicated that intake of coffee components, CA and CGA, enhanced the antioxidative properties of glial cells and prevents rotenone-induced neurodegeneration in both the brain and myenteric plexus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“administration of CA or CGA at least partially prevented the changes induced by rotenone, which affected both neurons and enteric glial cells in the intestinal myenteric plexus of treated mice.”
From Effects of Coffee and Its Components on the Gastrointestinal Tract and the Brain–Gut Axis (2020) · cites this paper as [224]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Importantly, all these effects were reproduced in vitro.”
From Effects of Coffee and Its Components on the Gastrointestinal Tract and the Brain–Gut Axis (2020) · cites this paper as [224]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 1×
“to reach the substantia nigra, eventually leading to motor dysfunction [5].”
BackgroundChronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683 · cited 2×
“Studies have demonstrated neurotoxic effects of rotenone in vitro and in vivo [11,13,14].”
BackgroundGastrointestinal Dysfunction in Parkinson’s Disease
Fasano, A., Visanji, N. P., Liu, L. W. C., Lang, A. E., & Pfeiffer, R. F. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00007-1 · Cited by 1,016
Gastrointestinal dysfunction in Parkinson's disease
Pfeiffer, R. F. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00307-7 · Cited by 925
Frequency of Bowel Movements and the Future Risk of Parkinson’s Disease
Abbott, R. D., Petrovitch, H., White, L. R., Masaki, K. H., Tanner, C. M., Curb, J. D., Grandinetti, A., Blanchette, P. L., Popper, J. S., & Ross, G. W. (2001) · Neurology · doi:10.1212/wnl.57.3.456 · Cited by 839 · cited 1×
“Recently, a large-scale prospective study demonstrated that lower bowel movement frequencies predicted the future PD crisis [4].”
BackgroundAssociation of coffee and caffeine intake with the risk of Parkinson disease
Ross, G. W. (2000) · JAMA · doi:10.1001/jama.283.20.2674 · Cited by 778 · cited 2×
“Considering the epidemiological data showing an inverse association of daily coffee consumption with PD risk [18,19], we examined the neuroprotective effects of CA and CGA against rotenone neurotoxicity.”
BackgroundSherer, T. B., Kim, J.-H., Betarbet, R., & Greenamyre, J. T. (2003) · Experimental Neurology · doi:10.1006/exnr.2002.8072 · Cited by 708 · cited 1×
“Studies have demonstrated neurotoxic effects of rotenone in vitro and in vivo [11,13,14].”
BackgroundProspective Study of Caffeine Consumption and Risk of Parkinson’s Disease in Men and Women
Ascherio, A., Zhang, S. M., Hernán, M. A., Kawachi, I., Colditz, G. A., Speizer, F. E., & Willett, W. C. (2001) · Annals of Neurology · doi:10.1002/ana.1052 · Cited by 677 · cited 2×
“Considering the epidemiological data showing an inverse association of daily coffee consumption with PD risk [18,19], we examined the neuroprotective effects of CA and CGA against rotenone neurotoxicity.”
BackgroundPathogenesis of Parkinson disease—the gut–brain axis and environmental factors
Klingelhoefer, L., & Reichmann, H. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.197 · Cited by 598 · cited 5×
“In addition, rotenone has been shown to reproduce PD pathology in both the CNS and ENS [15–17].”
BackgroundInfluentialA timeline for Parkinson's disease
Hawkes, C. H., Del Tredici, K., & Braak, H. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.08.007 · Cited by 594 · cited 5×
“In addition, rotenone has been shown to reproduce PD pathology in both the CNS and ENS [15–17].”
BackgroundInfluential
Cited by
Nguyen, V., Taine, E. G., Meng, D., Cui, T., & Tan, W. (2024) · Nutrients · doi:10.3390/nu16070924 · Cited by 378
“CGA combined with ca ff eic acid prevents rotenone-caused Parkinsonian pathology in nigral dopaminergic and intestinal enteric neurons [224].”
BackgroundNeuroprotective Effects of Coffee Bioactive Compounds: A Review
Socała, K., Szopa, A., Serefko, A., Poleszak, E., & Wlaź, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010107 · Cited by 248
Therapeutic Implications of Caffeic Acid in Cancer and Neurological Diseases
Alam, M., Ahmed, S., Elasbali, A. M., Adnan, M., Alam, S., Hassan, M. I., & Pasupuleti, V. R. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.860508 · Cited by 230
Neuron-Astrocyte Interactions in Parkinson’s Disease
Miyazaki, I., & Asanuma, M. (2020) · Cells · doi:10.3390/cells9122623 · Cited by 186
Self-citationUsing Rotenone to Model Parkinson’s Disease in Mice: A Review of the Role of Pharmacokinetics
Innos, J., & Hickey, M. A. (2021) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00522 · Cited by 145
Effects of Coffee and Its Components on the Gastrointestinal Tract and the Brain–Gut Axis
Iriondo-DeHond, A., Uranga, J. A., del Castillo, M. D., & Abalo, R. (2020) · Nutrients · doi:10.3390/nu13010088 · Cited by 126
Dietary Phenolic Compounds: Their Health Benefits and Association with the Gut Microbiota
Matsumura, Y., Kitabatake, M., Kayano, S.-I., & Ito, T. (2023) · Antioxidants · doi:10.3390/antiox12040880 · Cited by 139
“…acid Parkinson’s disease protection of rotenone-induced neurodegeneration of both nigral dopaminergic and enteric neurons, upregulation of metallothionein Miyazaki et al., 2019 [196] chlorogenic acid Parkinson’s disease attenuation of oxidative stress andneuroinflammation in MPTP-poisoned mice…”
BackgroundBalakrishnan, R., Azam, S., Cho, D.-Y., Su-Kim, I., & Choi, D. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6680935 · Cited by 133
Miyazaki, I., Isooka, N., Imafuku, F., Sun, J. Y., Kikuoka, R., Furukawa, C., & Asanuma, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093254 · Cited by 111
Self-citationYan, L., Guo, M.-S., Zhang, Y., Yu, L., Wu, J.-M., Tang, Y., Ai, W., Zhu, F.-D., Law, B. Y.-K., Chen, Q., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/5288698 · Cited by 97
“It is reported that mitochondrial-mediated apoptotic senescence of DA neurons is implicated in MPTPintoxicated PD mouse, while the treatment of CGA can inhibit the ratio of Bax/Bcl-2 and caspase-3 activation, which is associated with the downregulation of GSK3β via activating the Akt/ERK signaling pathway [235, 236].”
Fukutomi, R., Ohishi, T., Koyama, Y., Pervin, M., Nakamura, Y., & Isemura, M. (2021) · Molecules · doi:10.3390/molecules26020415 · Cited by 82
Modulation of Glial Function in Health, Aging, and Neurodegenerative Disease
Hanslik, K. L., Marino, K. M., & Ulland, T. K. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.718324 · Cited by 72
The potential applications of traditional Chinese medicine in Parkinson's disease: A new opportunity
Chen, J., Xu, J., Huang, P., Luo, Y., Shi, Y., & Ma, P. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112866 · Cited by 48
The Rotenone Models Reproducing Central and Peripheral Features of Parkinson’s Disease
Miyazaki, I., & Asanuma, M. (2020) · NeuroSci · doi:10.3390/neurosci1010001 · Cited by 48
Self-citationMontalbán-Rodríguez, A., Abalo, R., & López‐Gómez, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021294 · Cited by 44
“Searching for possible treatments that can alleviate the effects of this disease, the neuroprotective effects of the coffee compounds caffeic acid (CA) and chlorogenic acid (CGA) against rotenone-induced degeneration in C57BL/6J mice have been examined [67].”
BackgroundInfluentialMultifunctional Metallothioneins as a Target for Neuroprotection in Parkinson’s Disease
Miyazaki, I., & Asanuma, M. (2023) · Antioxidants · doi:10.3390/antiox12040894 · Cited by 39
Self-citationBenefits of p-coumaric acid in mice with rotenone-induced neurodegeneration
Dolrahman, N., Mukkhaphrom, W., Sutirek, J., & Thong-asa, W. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01113-2 · Cited by 26
Liu, J., Zhang, Y., Ye, T., Yu, Q., Yu, J., Yuan, S., Gao, X., Wan, X., Zhang, R., Han, W., et al. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c06998 · Cited by 21
Yang, L., Nao, J., & Dong, X. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c02787 · Cited by 22
Nutraceuticals and Enteric Glial Cells
López‐Gómez, L., Szymaszkiewicz, A., Zielińska, M., & Abalo, R. (2021) · Molecules · doi:10.3390/molecules26123762 · Cited by 19
Cao, J., Duan, Y., Liu, Y., Liu, H., Wei, C., Wang, J., Qin, X., Wang, X., & Li, Z. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112247 · Cited by 14
Almeida, P. P., Gomes, A. L. T., & Stockler‐Pinto, M. B. (2022) · Nutrition Reviews · doi:10.1093/nutrit/nuac030 · Cited by 13
Enteric glia as a player of gut-brain interactions during Parkinson’s disease
Thomasi, B. B. D. M., Valdetaro, L., Ricciardi, M. C., de Carvalho, M. G., Tavares, I. F., & Gomes, A. L. T. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1281710 · Cited by 12
Samur, D. N., Yıldırım, S., Maytalman, E., Kalay, M., Tanrıöver, G., & Özbey, G. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110385 · Cited by 11
Miyazaki, I., Kikuoka, R., Isooka, N., Takeshima, M., Sonobe, K., Arai, R., Funakoshi, H., Quin, K. E., Smart, J. L., Zensho, K., et al. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111235 · Cited by 10
Self-citationRevealing the Curative Possibilities: A Comprehensive Exploration of Caffeic Acid
Goyal, A., Singh, V. D., Solanki, K., & Verma, A. (2024) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010309341240517071344 · Cited by 9
Green coffee extract attenuates Parkinson’s-related behaviors in animal models
Molska, G. R., de Paula-Freire, L. I. G., Sakalem, M. E., Köhn, D., Negri, G., Carlini, E. A., & Mendes, F. R. (2021) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765202120210481 · Cited by 10
Song, L.-Z.-X., Xu, N., Yu, Z. H., Yang, H., Xu, C., Qiu, Z., Dai, J., Xu, B., & Hu, X. (2023) · The Anatomical Record · doi:10.1002/ar.25148 · Cited by 14
“…PD in rats (Greene et al., 2009; Johnson et al., 2018), especially at low doses (2.5 mg/kg) of rotenone treatment, which has been further demonstrated in mice to provide replication of SNpc and myenteric nervous plexus neurodegeneration and the presence of α -Syn aggregates (Miyazaki et al., 2019).”
BackgroundInfluentialWang, X. J., Zhang, W., Wang, H. H., Zhao, Y., Wang, P., Wang, R., Sun, Y., Ren, F., & Li, Y. (2025) · Nutrients · doi:10.3390/nu17223519 · Cited by 9
“In vitro experiments further corroborated that pretreatment with CGA significantly enhanced the survival of primary enteric neurons exposed to rotenone and induced the upregulation of MT expression [106].”
Yin, D. X., Toyoda, H., Nozaki, K., Satoh, K., Katagiri, A., Adachi, K., Kato, T., & Sato, H. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223273 · Cited by 9
Song, L.-Z.-X., Li, Y., Qian, X., Xu, N., Yu, Z., Dai, J., Xu, B., & Hu, X. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2022.1092127 · Cited by 11
Rousseaux, C. G. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-16153-7.00004-6 · Cited by 8
Park, J. B. (2020) · Journal of Dietary Supplements · doi:10.1080/19390211.2020.1784347 · Cited by 7
“Several studies suggest that coffee consumption may have positive health benefits on several human diseases, such as liver disease, diabetes and degenerative diseases (Butt and Sultan 2011; Muriel and Arauz 2010; Santos and Lima 2016; Yan et al. 2018; Miyazaki et al. 2019).”
BackgroundInfluentialBasıt, A., Shahzad, R., Mueed, A., Muhammad, A., Wang, R., Liu, Y., Gong, X., Shahrokh, K., Arshad, M., & Shutian, T. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.106407 · Cited by 8
Portela, J. L., Bianchini, M. C., Roos, D. H., Ávila, D. S., & Puntel, R. L. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01974-3 · Cited by 5
“Accordingly, CA (a phenolic compound) and CAF (an alkaloid) are both known for their antioxidant potential (Suh et al. 2017; Machado et al. 2019; Miyazaki et al. 2019) as well as for their ability to improve mitochondrial function (Elekofehinti et al.”
BackgroundLiu, X., Martin, J. J. J., Li, X., Li, Q., Zhou, L., Li, R., Fu, D., & Cao, H. (2025) · LWT · doi:10.1016/j.lwt.2025.118292 · Cited by 7
Caffeic Acid and Human Health: Evidence-Based Roles in Disease Prevention and Treatment
Almatroodi, S. A., & Rahmani, A. H. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27114719 · Cited by 6
Almeida, P. P., Brito, M. L., Thomasi, B. B. D. M., Mafra, D., Fouque, D. P., Knauf, C., Gomes, A. L. T., & Stockler‐Pinto, M. B. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122793 · Cited by 4
Chlorogenic acid as a neuroprotectant
Soni, R., Sharma, N., Shah, J., & Khairnar, A. (2024) · Coffee in Health and Disease Prevention · doi:10.1016/b978-0-443-13868-3.00026-0 · Cited by 3
The Double‐Edged Sword: The Complex Function of Enteric Glial Cells in Neurodegenerative Diseases
Mendonça, I. P., & Peixoto, C. A. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70069 · Cited by 4
“Moreover, they found gut dysbiosis followed by a decreased abundance of SCFA-producing colonic bacteria in intestinal biopsies of individuals with PD.”
InfluentialSubba, R., Fasciolo, G., Petito, A., Geremia, E., Tomajoli, M. T. M., Mondal, A. C., Napolitano, G., & Venditti, P. (2025) · Antioxidants · doi:10.3390/antiox14121386 · Cited by 4
“Moreover, in a mouse model of neurodegeneration, CGA showed therapeutic potential by boosting antioxidant activity in astroglia [86].”
Kotormán, M., & Bedő, V. A. (2020) · Biologia Futura · doi:10.1007/s42977-020-00006-8 · Cited by 3
Therapeutic strategy for Parkinson’s disease: targeting zinc-binding protein in astrocytes
Miyazaki, I., & Asanuma, M. (2021) · Folia Pharmacologica Japonica · doi:10.1254/fpj.20082 · Cited by 2
Self-citationAnti-oxidants in astrocytes as target of neuroprotection for Parkinson’s disease
Asanuma, M., & Miyazaki, I. (2020) · Folia Pharmacologica Japonica · doi:10.1254/fpj.20071 · Cited by 4
Self-citationModulation of enteric glial cells by nutraceuticals during pathological processes
López‐Gómez, L., & Abalo, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23763-8.00010-5 · Cited by 3
Zensho, K., Miyazaki, I., Isse, A., MISAWA, I., Masai, K., Oka, M., Tsukahara, H., & Asanuma, M. (2025) · Pediatric Research · doi:10.1038/s41390-025-03920-6 · Cited by 1
Self-citationEnteric Nervous System Damage by Food Contaminants: A Pathway to Neurodegeneration?
Ramos, H., Araújo, A. M., Ferreira, I. M. P. L. V. O., & Faria, M. Â. (2026) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.70448 · Cited by 1
“For instance, coffee polyphenols (caffeic acid, chlorogenic acid) were tested against rotenone-induced ENS toxicity in mice (Miyazaki et al. 2019 ).”
InfluentialWybrane zagadnienia z zakresu bromatologii t.2
Babicz, M., Kropiwiec-Domańska, K., & Szymonowska, U. (2022) · doi:10.24326/mon.2022.6 · Cited by 1
Chlorogenic acid in energy metabolism on efficacy and mechanisms of action
Li, X., & Jia, H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13868-3.00055-7 · Cited by 1
Effect of Coffee, Tobacco, and Alcohol on Parkinson’s Disease
Seol, W., Kim, H. J., & Son, I. (2021) · Journal of the Korean Neurological Association · doi:10.17340/jkna.2021.3.3
Modelling motor and non-motor signs of early-stage Parkinson's disease
Ivanov, M. V., & Kutukova, K. A. (2022) · Annals of Clinical and Experimental Neurology · doi:10.54101/acen.2022.2.6
Samur, D. N., Maytalman, E., & Zorlu, Ö. (2025) · OSMANGAZİ JOURNAL OF MEDICINE · doi:10.20515/otd.1672924
Lifestyle medicine for neuroprotection: evidence and implementation in Asian contexts
Kim, S., Chung, S. J., Yoon, S., Bloem, B. R., Postma, E., Kim, R., Fujioka, S., Nagaishi, Y., Phokaewvarangkul, O., Park, K. W., et al. (2026) · Journal of Neural Transmission · doi:10.1007/s00702-026-03294-x
Metadata
- Authors
- Miyazaki, I., Isooka, N., Wada, K., Kikuoka, R., Kitamura, Y., & Asanuma, M.
- Affiliations
- Okayama University (JP)
- Corresponding author
- Miyazaki, Ikuko
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2019-03-07
- Volume
- 8
- Issue
- 3
- Pages
- 221
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC6468520
- OpenAlex
- W2919600163
- Cited by
- 53
- References
- 50
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 7 · 2023: 7 · 2022: 9 · 2021: 8 · 2020: 10 · 2019: 1
- FWCI
- 4.72
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- All Japan Coffee Association (2016, 2018)
- Japan Society for the Promotion of Science (JP25461279, JP16K09673)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Pharmacology (medical) › Coffee research and impacts
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- caffeic acid, chlorogenic acid, rotenone, Parkinson's disease, neuroprotection, neurodegeneration, dopaminergic neurons, enteric neurons, myenteric plexus, metallothionein, astrocytes, oxidative stress, antioxidant activity, mitochondrial complex I inhibitors, glial cells
- MeSH terms
- Animals, Astrocytes, Caffeic Acids, Chlorogenic Acid, Coffee, Intestines, Male, Mesencephalon, Metallothionein, Mice, Inbred C57BL, Myenteric Plexus, Nerve Degeneration, Neuroglia, Rotenone, Down-Regulation, Up-Regulation, Neostriatum, Rats, Sprague-Dawley, Enteric Nervous System, Neuroprotective Agents, Dopaminergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.